How to Prevent COVID-19 Vaccination From Interfering With Cancer Imaging
Education, communication, and coordination are key.
COVID19
Seroconversion After Full COVID-19 Vaccination Lower With Hematologic Malignancies, Lowest With Multiple Myeloma
A single-center study found anti-COVID-19 protection lowest in patients with MM at 2 weeks after their second BNT162b2 mRNA shot than did patients with myeloproliferative malignancies, and was highest in older patients without cancer.
Mortality Risk Factors in Patients With Cancer and COVID-19 Identified
Investigators zero in on mortality risk factors in patients with cancer who contract COVID-19.
Pathologic Outcomes in Prostate Cancer Cases Worsened During Pandemic
Compared with before the pandemic, men undergoing radical prostatectomy during the pandemic were more likely to have extraprostatic disease, according to investigators.
Two Doses of COVID-19 Vaccine Appear Necessary to Protect Cancer Patients on Active Treatment
Cancer patients had a low rate of seropositivity after the first vaccine dose but not after the second dose.
Response to COVID-19 Vaccine Variable in Multiple Myeloma Patients
Considerable variation seen in magnitude of antibody response, from 5 to 7,882 AU/mL, following two doses of mRNA COVID-19 vaccine.
Public Interest in Cancer Screenings Decreased Early During the COVID-19 Pandemic
Researchers observed a “sharp” decline in public interest.
ASCO and Friends: Cancer Patients Should Be Included in COVID-19 Vaccine Trials
A statement recommends including cancer patients and survivors in COVID-19 vaccine trials.
Decline in Cancer-Related Services Seen During Pandemic
Nadir in pathology reports from GA, LA SEER registries seen in early April 2020, with 42.8 percent fewer reports compared with April 2019.
Risk Factors Identified for All-Cause Mortality in Cancer Patients With COVID-19
Researchers assessed the risk for all-cause mortality in cancer patients with COVID-19.
- Loading...
Loading...
Next post in General Oncology
Loading... 
Loading...